Latest News about MDGL
Recent news which mentions MDGL
Is Madrigal Pharmaceuticals Stock a Better Buy Than Eli Lilly and Novo Nordisk After Its Huge FDA Win?
March 19, 2024
From Motley Fool
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
March 18, 2024
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
March 18, 2024
From Benzinga
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
March 17, 2024
From Motley Fool
Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 15, 2024
From Benzinga
FDA Conditionally Approves Madrigal Pharmaceuticals' Resmetirom As First Treatment For Fatty Liver Disease With Scarring
March 15, 2024
From Benzinga
Why Is Geron (GERN) Stock Up 94% Today?
March 15, 2024
From InvestorPlace
Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday
March 15, 2024
From Benzinga
From InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 15, 2024
From Benzinga
Why Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
March 15, 2024
From Benzinga
From InvestorPlace
From Benzinga
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 14, 2024
From Benzinga
From Motley Fool
1 Wall Street Analyst Thinks Madrigal Pharmaceuticals Stock Is Going to $347. Is It a Buy Around $247?
March 05, 2024
Tickers
MDGL
From Motley Fool
1 Beaten-Down Stock That Could Soar by 40%, According to Wall Street
February 23, 2024
Tickers
MDGL
From Motley Fool
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 06, 2024
From Benzinga
2 Rising Biotechs That Could Become the Next Novo Nordisk
January 29, 2024
From Motley Fool
2 Stocks That Could Soar This Year: Are They Buys?
January 22, 2024
From Motley Fool
Liver Disease Player 89Bio Downgraded: Analyst Sees Short-Term Uncertainties In Fatty Liver Drug Development
January 12, 2024
From Benzinga
3 Stocks That Could Be Monster Winners in 2024
December 30, 2023
From Motley Fool
Why Comtech Telecommunications Shares Are Trading Lower By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 08, 2023
From Benzinga
These 2 Stocks Could Be About to Soar: Are They Buys?
December 07, 2023
From Motley Fool
Got $2,000? 3 Growth Stocks to Buy That Could Double Your Money
November 30, 2023
From Motley Fool
From Benzinga
The 3 Most Undervalued Biotech Stocks to Buy: November 2023
November 14, 2023
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.